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Natural  cell-mediated  cytotoxicity  (NCMC)  has  been  defined  as  the  ability of 
lymphoid cells derived from normal donors to lyse a  number of tumor target cells in 
vitro (1, 2). In mice, at least two distinct NCMC effector systems have been identified: 
natural  killer (NK)  (1,  2)  and  natural  cytotoxic (NC)  cells  (3).  NK  cells were  first 
described by their cytotoxicity against lymphoid tumor targets (1, 2) and subsequently 
shown to lyse solid tumors as well (4). NC cells were described by our laboratory and 
shown  primarily to lyse nonlymphoid solid tumor cell lines  (3-5).  NK and NC  cells 
are active in the absence of known priming, present in athymic nude mice, of a  still 
undefined  lineage,  and  do  not  have  properties  of conventional  T  cells,  B  cells, or 
macrophages (1-7). However, NK and NC cells differ in strain distribution of activity 
and  expression  of cell  surface  antigens  (1-8).  NK  cell  activity  is  augmented  by 
interferon  (IFN), IFN-inducing agents  (9), and  the  lymphokine interleukin  2  (IL-2) 
(10,  11).  NC  cell activity is not augmented by IFN or IFN-inducing agents  (4), and 
when augmented lysis is detected against a  particular NC-susceptible target, it is due 
to a  superimposed NK-augmented component  (4). 
In the present study we show that in vitro exposure to IL-2 augments both NK and 
NC  activity,  while  another  lymphokine  or  monokine,  interleukin  3  (IL-3)  (12), 
augments only NC activity. Conversely, and included for the sake of comparison, the 
IFN-inducer poly-IC augments NK but not NC cell activity. We also show here that 
the IL-2 augmented NK and NC cytotoxic activities are the function of precursor and 
effector  cells  with  different  expression  of  the  Qa  5  marker,  which  is  present  on 
spontaneous and augmented NK cells (13), but not on NC cells (8). This supports our 
contention that NCMC  is mediated by at least two distinct subpopulations of related 
but distinct effector cells. 
Materials and  Methods 
Animals.  All experiments were done with spleen cells from 6-8-wk-old C57BL/6J  mice of 
both sexes, obtained from The Jackson Laboratory, Bar Harbor, ME. 
Target  Cells and Cell Preparation Procedures.  The YAC-1 lymphoma targets were obtained in 
1978 from the late Dr. G. Cudkowicz and kept in culture as described (8). The WEHI-164, a 
chemically induced fibrosarcoma of BALB/c origin that is an exclusive NC target (14, see also 
ref.  4)  was obtained  from  Dr.  R.  C.  Burton  when  at  the  Massachusetts General  Hospital, 
Boston, MA, and kept in culture as described (4).  Spleen cell suspensions for the assays were 
prepared as before (3). 
Assay Systems.  NK activity was tested against YAC:-I  and NC activity was tested against 
WEHI  164 targets, using a standard 18-h SlCr release assay, as described (4). 
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TABLE  I 
Augmentation and Mediation of NC and NK Cell Activity 
Percent cytotoxicity~: 
Group  Target  Effectors*  Control~  Anti-Qa-5 +  C§ 
100:1  50:1  100:1  50:1 
1  YAC- 1  Fresh NK  37  26  0  0 
24 h  0  0  0  0 
Poly-IC  34][  32[f  1  4 
2  YAC- 1  Fresh NK  23  17  8  6 
24 h  9  7  4  4 
IL-2  4211  38J]  9  4 
IL-3  12  7  4  5 
3  WEHI-164  Fresh NC  24  18  ND¶  ND 
24 h  23  17  ND  ND 
Poly-IC  32  16  ND  ND 
4  WEHI- 164  Fresh NC  52  35  47  31 
24 h  37  29  47  33 
IL-2  7411  5311  7011  4811 
IL-3  6211  5611  6511  5511 
* C57BL/6J spleen cells either fresh or cultured as indicated alone for 24 h or with poly-IC 
at 25 #g/ml (poly-IC), IL-2 (at 20 U/ml), or IL-3 (at 20 EDS0/rnl) for 24 h  (see Materials 
and Methods for further details) were tested for NK and NC activity in 18 h SlCr-release 
assays  against  YAC-1  (an  NK-susceptible  target)  and  WEHI-164  (an  NC-susceptible 
target, resistant to NK lysis; see ref. 4 and 14). For further details on assays, see Materials 
and Methods. 
~: Percent cytotoxicity calculated as in Material and Methods. 
§ These cells were tested in the NK-NC assay against YAC-1  or WEHI-164 targets after in 
vitro treatment with anti-Qa5 monoclonal and C  (see Materials and Methods for details). 
§ Significant differences,  P <  0.05 from the 24 h control. 
¶ Not done. 
Preincubations of Effector Cells.  Spleen cells were preincubated for 24 h  in the same medium 
as used for the assays (4), either alone (indicated in Table I as "24 h") or in the presence of 25 
/~g/ml of poly-IC  (4) or 20 U/ml  of IL-2 or IL-3  (20 ED50/ml)  at cell concentrations of 5  × 
10e/ml.  The IL-2 was semi-purified from Con-A-stimulated rat spleen cell cultures, with the 
mitogen removed by ammonium sulfate precipitation and Sephadex G-100 chromatography 
(15). The units defined as in refs.  15 and 16. The IL-3 was provided by Dr.J.N.  Ihle, Frederick 
Cancer Center, Frederick, MD, and purified to homogeneity from WEHI-3 supernatants (12). 
IL-3  was  received  at  a  concentration  of  103  ED50/ml  in  saline and  further  diluted  in  the 
medium described above. For definition of IL-3 units see ref.  12. The IL-2 preparation used in 
these experiments had no IL-3 activity as measured by its ability to support the proliferation of 
an  IL-3-dependent  cell  line  32D  cl  5,  obtained  from  Dr.  J.  S.  Greenherger,  Sidney  Farber 
Cancer Center, Boston, MA, using a  procedure developed in our laboratory (R. A. Miller and 
O. Stutman, manuscript in preparation). Similarly, the IL-3 preparation had no detectable IL- 
2 activity when measured in a  similar fashion, using an IL-2-dependent T  cell line (15,  16). 
Treatment of Cells with Anti-Qa5.  The monoclonal antibody anti-Qa5 was obtained from Dr. 
U.  Hammerling of Memorial Sloan-Kettering Cancer Center and  used  for mass lysis of cells 
(4). The effector cells were either treated with anti-Qa-5 and C  as fresh cells or after the 24 h 
preincubations, as described in Tables I  and II. 
Results 
Table  I  shows the effects of IL-2, IL-3, and  poly-IC on spleen NK  and  NC  activity. 
Groups  1  and  2  show  that  NK  cell  activity,  measured  as  lysis  of  the  lymphoma 
YAC-I  in  an  18-h 51Cr release assay,  was significantly augmented  by preincubation 
of the cells with poly-IC or IL-2 for 24 h, when  compared  with cells incubated  alone 1072  LATTIME ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE  II 
Pretreatment of Spleen Cells with Anti-Qa5 and C Removes the Poly-IC and 
IL-2 Augmentable ArK Precursor While Not Affecting the [L-2 and [L-3- 
responsive NC Precursor Population 
Group  Target  Effector* 
Percent cytotoxicity:~ 
100:1  50:l  25:1 
1  YAC- 1 
2  YAC- 1 
3  WEHI- 164 
Fresh NK  23  17  ND§ 
24 h  9  7  ND 
IL-2  4211  3811  ND 
Pre-Qa-5 + C  6  4  ND 
Pre-Qa-5 + IL-2  6  4  ND 
Fresh NK  ND  10  8 
24h  ND  0  0 
Poly-IC  ND  2411  19[[ 
Pre-Qa-5 + C  ND  0  0 
Pre-Qa-5 + poly-IC  ND  1  0 
Fresh NC  52  35  ND 
24 h  37  30  ND 
IL-2  741[  53t]  ND 
m-3  621[  5611  ND 
Pre-Qa-5 + C  43  30  ND 
Pre-Qa-5 +  IL-2  6ill  4711  ND 
Pre-Qa-5  +  IN-3  56[I  4411  ND 
* C57BI/6J  spleen cells fresh, or cultured as indicated were used as effectors 
for the assays (fresh, cultured alone for 24 h, (denoted  24 h), cultured with 
poly-IC (poly-IC),  IL-2  (IL-2)  or  IL-3  (tL-3)  for  24  h,  and spleen  cells 
pretreated with anti-Qa-5 +  C cultured alone (Pre-Qa-5  +  C) or with the 
agents described above). 
:~ All studies were done using 18-h 51Cr assays. For description of the assay and 
effector cells see Materials and Methods. 
§ Not done. 
I[ P <  0.05 significantly different from control  (24 h or pre-Qa-5 + C), 
for 24 h  (which showed the characteristic loss of NK activity) (l, 2, 5), and comparable 
to  the  values observed  with  fresh  NK  cells.  Little  if any  effect  of IL-3  on  NK  cell 
activity was noted (group 2, Table I). Table I  also shows that  the augmented lysis of 
the YAC target by the NK cells treated with poly-IC or IL-2 is the function of a  Qa- 
5 + effector cell, as is the case for fresh NK  cells (8,  13). 
When  similarly pretreated  spleen cells were  assayed  for  their capacity  to  lyse the 
NC-sensitive,  NK-resistant  fibrosarcoma  WEHI-164  in  an  18-h  ~Cr  release  assay 
(groups 3 and 4  in Table I), a  different pattern of activities was noted. Poly-IC failed 
to induce any increase in NC cell activity (4), whereas both IL-2 and IL-3 treatment 
lead  to  a  significant augmentation  of lysis of the  NC-susceptible target  (group  4  in 
Table I). The augmented activity after IL-2 or IL-3 treatment was consistently above 
the values observed with either spleen cells incubated alone for  24 h  or fresh spleen 
NC cells. Groups  3  and 4  in Table I  also show  that  the activity of fresh  NC cells is 
comparable  to that  of cells incubated alone for  24 h, a  stability in culture  (3, 5,  18) 
that contrasts with the labile NK  cells  (1, 2, 5,  18). As also shown in groups  3 and 4 
in Table I  and in contrast with the NK  cell findings, the effector cells responsible for 
the  augmented  lysis of the  WEHI-164  target  induced  by both  IL-2  and  IL-3 were 
Qa-5-, as was the case for fresh spleen NC cells (8). This type of result with NK  and 
NC  cells was  observed  in each  of five experiments.  In summary,  NK  activity,  both LATTIME ET AL.  BRIEF DEFINITIVE REPORT  1073 
spontaneous and augmented (by poly-IC and IL-2) was mediated by a Qa-5 + effector, 
whereas the spontaneous or augmented (by IL-2 or IL-3) NC activity was the function 
of a Qa-5- effector cell. 
Table II shows that the difference in Qa-5 surface phenotype between the NK and 
NC  effector cells  is  also  observed  at  the  level of the  augmentable  precursor  cells. 
Pretreatment of the spleen cells with anti-Qa 5 and C before the culture with poly-IC 
or IL-2 completely abrogated the augmentation of NK cell activity (groups  1 and 2 
in  Table II); thus,  the augmentable  NK precursor is Qa-5 +,  as observed in  studies 
using IFN (17).  Conversely, group 3 in Table II shows that pretreatment of the spleen 
cells with anti-Qa-5 +  C  had no effect on the augmentation of NC cell activity by IL- 
2  and  IL-3;  thus,  the  augmentable  NC  precursor  is  Qa-5-,  as  is  the  case  for  the 
spontaneous and augmented NC effector (8)  (Table I). 
Discussion 
The results  presented  here add  two more properties to support  our views on the 
heterogeneity of effector cells mediating NCMC (3). They show that although a factor 
such as IL-2 can augment both NK and NC activities, it does so by acting on distinct 
cell populations  (Qa-5  + vs. Qa-5-). Our results also show that the cytotoxic activity 
of NK and NC cells are affected by different factors, with poly-IC (and IFN) (4, 9,  17) 
augmenting  NK but  not  NC  activity, and  IL-3  (12)  augmenting  NC  but  not  NK 
activity. 
Although we (3-8, 18) and others (14,  17,  19) have described a variety of properties 
of the NC system, we have been unable to ascribe the NC cell to a particular lineage. 
A similar problem remains with the NK cell (1, 2, 20). Although we have been unable 
to identify any NC-associated cell surface markers, we do know that NC cells lack T, 
B,  NK,  and  macrophage-associated antigens  (5,  8,  18).  It  is  tempting to  speculate 
from the present findings that since both IL-2 and IL-3 are soluble factors associated 
with  some  stages  of T  cell  differentiation  or  function  (12,  21),  and  both  factors 
augment  NC cell  activity, NC cells may be related  in some way to  the  T  lineage. 
Without  further  evidence,  however,  this  remains  only a  speculative  proposition  at 
present. 
In general, IL-2 induces responses that have been associated with Thy-1 + popula- 
tions, both in T  (21) and NK studies (17). Our demonstration that IL-2 also augments 
the activity of NC cells, which are Thy- 1- (5, I8), raises several possible interpretations: 
(a) IL-2 may possess a broader range of activities than thus far described, as seems the 
case for other hemopoietic growth factors (22) 7 (h) The activity that we have ascribed 
to augmented NC cells may be due to a  Thy-1 + Qa-5- population of the anomalous 
killer  (AK)  type  (23).  The  fact that  the  IL-2 augmentable and  effector cell  in  our 
system are both Q a-5- would eliminate the possibility of it being a  cell of the NKT 
type described by Minato et al.  (17).  (c)  the IL-2 preparation used has other factors 
besides  IL-2. Our  previous studies,  as well as those  described  in  this  report, would 
suggest the first interpretation, although the third interpretation cannot be completely 
excluded.  We have previously reported that removal of Thy-1 + cells from spleen or 
marrow had no effect on NC  cell activity  (5,  18),  and  pretreatment  of spleen cells 
with monoclonal anti-Thy-1 or anti-Lyt-2 and C  does not affect the augmentation of 
NC activity by IL-2 (our unpublished results). Furthermore, as shown in Tables I and 
II, IL-2 treated Q a-5- cells show augmented lysis only of the NC target, while failing 
to lyse the YAC-1 line. It is doubtful that an AK-like cell would show such NC target 1074  LATTIME ET AL.  BRIEF  DEFINITIVE REPORT 
preference  (23). The possibility that  factors other than  IL-2 might be present  in the 
IL-2 used cannot be ruled out. However, since as described above, the IL-2 preparation 
used did not contain any IL-3 activity, we may conclude that the augmented NC cell 
activity is probably a  function of the IL-2 in our preparation. 
In addition  to the  apparent  capacity to augment  NC cell  activity, IL-3 has  been 
shown to have at least two effects: it can induce the expression of the T  cell-associated 
enzyme 20-alpha-hydroxysteroid dehydrogenase, probably related to some early stages 
of thymocyte  and  T  cell  development  (12)  and  can  promote  the  growth  of IL-3- 
dependent  cell  lines  with  either  a  T-like  or  a  "mast  cell"-like  phenotype  (12).  A 
comparison between  NC  cells  and  some of the IL-3-responsive populations  or IL-3- 
dependent  cell lines shows some similarities,  i.e., tissue distribution  and lack of some 
surface markers  (3, 5, 8,  12),  but they are far from conclusive, although they suggest 
that  NC cells and other IL-3-responsive populations may be related,  especially since 
some of the IL-3 dependent  cell lines (12)  appear to have NC-like cytotoxicity (24). 
Three conclusions regarding heterogeneity of NCMC effector cells can be derived 
from the present studies. First, the demonstration that NC and NK cells differ in their 
regulation strengthens our conclusions that the two activities are functions of distinct, 
although  perhaps  related,  cellular  populations.  Second,  the  demonstration  that  a 
second  NCMC  effector  system,  distinct  from  NK,  and  lacking  T  cell  markers,  is 
regulated by IL-2 tentatively suggests that the lymphokine may have a broader range 
of activities  than  previously described  (an  alternative  view being that  both NC and 
NK systems are affected by IL-2 because they are somewhat related to the T  lineage). 
Third,  the  augmentation  of NC  cell  activity  by  IL-3  suggests  that  NC  cells  may 
belong to the group of IL-3 dependent cells (12), although it is still not clear from this 
fact whether  they belong to any of the  particular  cell  lineages  that  are  affected by 
IL-3. 
Summary 
Murine  natural  killer  (NK)  and  natural  cytotoxic  (NC)  cells  showed  different 
patterns  of augmentation  of lytic activity  after  preincubation  for  24  h  with  either 
poly-IC, interleukin 2 (IL-2), or interleukin  3 (IL-3): (a) Poly-IC augmented only NK 
ceils,  with  no  effect  on  NC  activity,  as  we  have  previously  observed  (4);  (b)  IL-2 
augmented both NK and NC activity; and (c) IL-3 augmented only NC lysis, without 
affecting NK activity.  In addition,  both  precursor  and  the augmented  effector ceils 
showed  differences  in  expression  of the  Qa-5  surface  marker:  NK  precursors  and 
effectors are Qa 5 +, whereas NC precursors and effector cells are Qa-5-, 
Received  for publication 9 November 1982 and in revised  form 6 December 1982. 
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